MENU
+Compare
NTRA
Stock ticker: NASDAQ
AS OF
Oct 14 closing price
Price
$172.81
Change
-$1.36 (-0.78%)
Capitalization
23.72B

NTRA Natera Forecast, Technical & Fundamental Analysis

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology... Show more

Industry: #Biotechnology
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NTRA with price predictions
Oct 08, 2025

NTRA sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for NTRA moved above the 200-day moving average on September 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2025. You may want to consider a long position or call options on NTRA as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 288 cases where NTRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NTRA moved out of overbought territory on September 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on September 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NTRA broke above its upper Bollinger Band on September 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.048) is normal, around the industry mean (11.719). P/E Ratio (0.000) is within average values for comparable stocks, (137.569). NTRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.765). NTRA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (11.574) is also within normal values, averaging (9.493).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTRA is expected to report earnings to fall 50.73% to -36 cents per share on November 05

Natera NTRA Stock Earnings Reports
Q3'25
Est.
$-0.36
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.14
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.31
The last earnings report on August 07 showed earnings per share of -74 cents, missing the estimate of -62 cents. With 882.03K shares outstanding, the current market capitalization sits at 23.72B.
A.I. Advisor
published General Information

General Information

a genetic testing company which develops proprietary bioinformatics-based technology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13011 McCallen Pass
Phone
+1 650 980-9190
Employees
3018
Web
https://www.natera.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GBF105.920.19
+0.17%
iShares Government/Credit Bond ETF
FELC36.85-0.08
-0.22%
Fidelity Enhanced Large Cap Core ETF
FPA36.87-0.35
-0.95%
First Trust AsiaPac ex-Jpn AlphaDEX® ETF
EMEQ36.13-0.53
-1.44%
Macquarie Focused Emerging Mrkts Eq ETF
NML8.18-0.13
-1.56%
Neuberger Berman Energy Infrastructure and Income Fund

NTRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with GH. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+2.89%
GH - NTRA
57%
Loosely correlated
-3.88%
VCYT - NTRA
56%
Loosely correlated
-2.04%
ISRG - NTRA
54%
Loosely correlated
+1.43%
GKOS - NTRA
48%
Loosely correlated
+0.64%
BSX - NTRA
46%
Loosely correlated
-0.48%
More